These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34710314)

  • 21. Post hoc analyses of data from a 90-day clinical trial evaluating the tolerability and efficacy of tapentadol immediate release and oxycodone immediate release for the relief of moderate to severe pain in elderly and nonelderly patients.
    Vorsanger G; Xiang J; Biondi D; Upmalis D; Delfgaauw J; Allard R; Moskovitz B
    Pain Res Manag; 2011; 16(4):245-51. PubMed ID: 22059194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of a fixed-dose opioid agonist/antagonist on constipation in patients on long-term opioids for non-malignant pain unable to tolerate laxatives.
    Mehta V; Alaward S; Kuravinakop S; Nikolic S
    Pain Physician; 2014; 17(5):415-24. PubMed ID: 25247899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Retrospective Observational Study of Factors Affecting the Efficacy of Concurrent Prescription of Naldemedine for Opioid-Induced Constipation Caused by Oxycodone Tablets.
    Yamada M; Jimaru Y; Torii S; Mitsuba N; Takahashi K
    Biol Pharm Bull; 2023; 46(12):1826-1831. PubMed ID: 38044102
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomised controlled trial with prolonged-release oral oxycodone and naloxone to prevent and reverse opioid-induced constipation.
    Meissner W; Leyendecker P; Mueller-Lissner S; Nadstawek J; Hopp M; Ruckes C; Wirz S; Fleischer W; Reimer K
    Eur J Pain; 2009 Jan; 13(1):56-64. PubMed ID: 18762438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fixed ratio (2:1) prolonged-release oxycodone/naloxone combination improves bowel function in patients with moderate-to-severe pain and opioid-induced constipation refractory to at least two classes of laxatives.
    Koopmans G; Simpson K; De Andrés J; Lux EA; Wagemans M; Van Megen Y
    Curr Med Res Opin; 2014 Nov; 30(11):2389-96. PubMed ID: 25265132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxycodone for cancer-related pain.
    Schmidt-Hansen M; Bennett MI; Arnold S; Bromham N; Hilgart JS
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD003870. PubMed ID: 28829910
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms that underlie μ-opioid receptor agonist-induced constipation: differential involvement of μ-opioid receptor sites and responsible regions.
    Mori T; Shibasaki Y; Matsumoto K; Shibasaki M; Hasegawa M; Wang E; Masukawa D; Yoshizawa K; Horie S; Suzuki T
    J Pharmacol Exp Ther; 2013 Oct; 347(1):91-9. PubMed ID: 23902939
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of tapentadol extended release on productivity: results from an analysis combining evidence from multiple sources.
    Cepeda MS; Sutton A; Weinstein R; Kim M
    Clin J Pain; 2012 Jan; 28(1):8-13. PubMed ID: 21646907
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of opioid receptor antagonists in the treatment of opioid-induced constipation: a review.
    Leppert W
    Adv Ther; 2010 Oct; 27(10):714-30. PubMed ID: 20799006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prolonged-Release Oxycodone/Naloxone Improves Anal Sphincter Relaxation Compared to Oxycodone Plus Macrogol 3350.
    Poulsen JL; Brock C; Grønlund D; Liao D; Gregersen H; Krogh K; Drewes AM
    Dig Dis Sci; 2017 Nov; 62(11):3156-3166. PubMed ID: 28986667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quality of life benefits and cost impact of prolonged release oxycodone/naloxone versus prolonged release oxycodone in patients with moderate-to-severe non-malignant pain and opioid-induced constipation: a UK cost-utility analysis.
    Dunlop W; Uhl R; Khan I; Taylor A; Barton G
    J Med Econ; 2012; 15(3):564-75. PubMed ID: 22313329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methylnaltrexone for the treatment of opioid-induced constipation and gastrointestinal stasis in intensive care patients. Results from the MOTION trial.
    Patel PB; Brett SJ; O'Callaghan D; Anjum A; Cross M; Warwick J; Gordon AC
    Intensive Care Med; 2020 Apr; 46(4):747-755. PubMed ID: 32016532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methylnaltrexone for reversal of constipation due to chronic methadone use: a randomized controlled trial.
    Yuan CS; Foss JF; O'Connor M; Osinski J; Karrison T; Moss J; Roizen MF
    JAMA; 2000 Jan; 283(3):367-72. PubMed ID: 10647800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combatting pain after orthopedic/trauma surgery- perioperative oral extended-release tapentadol vs. extended-release oxycodone/naloxone.
    Haeseler G; Schaefers D; Prison N; Ahrens J; Liu X; Karch A
    BMC Anesthesiol; 2017 Jul; 17(1):91. PubMed ID: 28693439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of oxymorphone extended release in chronic low back pain: results of a randomized, double-blind, placebo- and active-controlled phase III study.
    Hale ME; Dvergsten C; Gimbel J
    J Pain; 2005 Jan; 6(1):21-8. PubMed ID: 15629415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term use of naldemedine in the treatment of opioid-induced constipation in patients with chronic noncancer pain: a randomized, double-blind, placebo-controlled phase 3 study.
    Webster LR; Nalamachu S; Morlion B; Reddy J; Baba Y; Yamada T; Arjona Ferreira JC
    Pain; 2018 May; 159(5):987-994. PubMed ID: 29419653
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identifying and Treating Opioid Side Effects: The Development of Methylnaltrexone.
    Moss J
    Anesthesiology; 2019 Jan; 130(1):142-148. PubMed ID: 30277930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does tapentadol affect sex hormone concentrations differently from morphine and oxycodone? An initial assessment and possible implications for opioid-induced androgen deficiency.
    Eichenbaum G; Göhler K; Etropolski M; Steigerwald I; Pergolizzi J; Kim M; Vorsanger G
    J Opioid Manag; 2015; 11(3):211-27. PubMed ID: 25985806
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of Lubiprostone for the Treatment of Opioid-Induced Constipation, Analyzed by Opioid Class.
    Webster LR; Brewer RP; Lichtlen P; Losch-Beridon T; Mareya S; Wang M
    Pain Med; 2018 Jun; 19(6):1195-1205. PubMed ID: 29897589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prolonged release oxycodone and naloxone treatment counteracts opioid-induced constipation in patients with severe pain compared to previous analgesic treatment.
    Koopmans-Klein G; Van Op den Bosch J; van Megen Y; Prenen H; Huygen F; Mancini I
    Curr Med Res Opin; 2017 Dec; 33(12):2217-2227. PubMed ID: 28805471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.